BIOREM closes private placement

NewsGuard 100/100 Score

BIOREM Inc. (TSXV:BRM) is pleased to announce the final closing of its private placement. In the initial closing, a total of 535 Units were issued for gross proceeds of $535,000.  Subsequently, an additional 124 units were closed which brought the total units closed to 659 units for total gross proceeds of $659,000.

Each Unit consisted of $1,000 principal amount of 8.00% convertible extendible secured subordinated debentures (the "Debentures") with a maturity date 2 years from the date of issuance and 2,808 common share purchase warrants (the "Warrants").  The Debentures are convertible into fully paid and non-assessable Common Shares of the Company at the option of the holder at any time over their term at a price of $0.178 per Common Share.  The maturity date of the Debentures can be extended to the fifth anniversary date of the issuance date of the Debentures by holders of 66.67% of the then outstanding principal amount of Debentures.  The Debentures can be prepaid in full at any time by the Company upon giving holders 15 days notice of prepayment.  Each Warrant entitles the holder to purchase one common share at a price of $0.178 per share for a period of two (2) years from issuance.  All securities issued pursuant to the Private Placement will be subject to a four month hold pursuant to applicable securities legislation. BIOREM intends to use the proceeds from the private placement for working capital and general corporate purposes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.